Video Viewpoint Strategy Session: Key Considerations in Managing Atopic Dermatitis in Black Patients

Video Viewpoint Strategy Session: Key Considerations in Managing Atopic Dermatitis in Black Patients is organized by i3 Health and will be held from Jul 27, 2022 - Jul 26, 2023.,Statement of Need:,Atopic dermatitis (AD), a severe form of eczema and intense pruritus, is associated with a substantial and multifaceted patient-reported burden that encompasses sleep disturbances, anxiety, depression, reduced function/productivity, and impaired quality of life. The incidence of AD is high, estimated to be approximately 15%-20% in children and 1%-3% in adults worldwide (Yong & Tay, 2017). Population studies within the United States have shown that AD disproportionately affects Black Americans compared with other ethnic groups (Brunner & Guttman-Yassky, 2019). Black Americans are more likely to experience severe disease and less favorable treatment outcomes (Kaufman et al, 2019). In this activity, Dr. Shawn Kwatra and Dr. Linda Stein Gold will direct thoughtful consideration of the health care disparities faced by Black patients with AD, best practices in diagnosis and assessment, and the applicability of novel therapeutic approaches for moderate-to-severe disease.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Recognize health care disparities experienced by Black patients with AD,• Evaluate best practices in diagnosis and assessment of AD in Black patients,• Assess the clinical utility of novel therapeutic approaches in Black patients with moderate-to-severe AD,• Counsel Black patients on self-care strategies to avoid flare-ups and optimize AD treatment outcomes,Faculty:,• Shawn Kwatra, MD (Chairperson),Director, Johns Hopkins Itch Center,Associate Professor of Dermatology,John Hopkins University School of Medicine,• Linda F. Stein Gold, MD,Director of Dermatology Clinical Research,Division Head of Dermatology,Henry Ford Health System,Presented by Dr. Shawn Kwatra, Director, John Hopkins Itch Center, Associate Professor of Dermatology, John Hopkins University School of Medicine and Dr. Linda Stein Gold, Director of Dermatology Clinical Research, Division Head of Dermatology, Henry Ford Health System, this expert led discussion will direct thoughtful consideration of the health care disparities faced by Black patients with AD, best practices in diagnosis and assessment, and the applicability of novel therapeutic approaches for moderate-to-severe disease.